Gyre Therapeutics, Inc. GYRE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.86M-364% | —— | $5.94M+108% | $1.58M-65.3% | $3.73M-62.4% | ||
| $672K+25.6% | $656K+42.3% | $649K+45.8% | $641K+181% | $535K+28.9% | ||
| $2.58M+409% | $4.6M+711% | $1.15M+384% | $906K+5,563% | $507K+4,509% | ||
| $3.18M+2,565% | —— | $4.68M— | $2.09M+138% | -$129K-104% | ||
| $178K+45.9% | $144K— | $668K-3.6% | $256K-82.4% | $122K-47.2% | ||
| -$3.06M-255% | —— | -$1.25M+47.8% | -$3.04M+63.2% | $1.97M+127% | ||
| $21K-98.4% | $318K-67.0% | $365K+12.7% | $22.35M+14,228% | $1.34M+104% | ||
| $431K-86.7% | —— | $3.91M+1,793% | $21.45M+257% | $3.23M+187% | ||
| $3M+1,296% | -$5.77M-114% | $4.01M— | $1.83M+126% | -$251K-109% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gyre Therapeutics, Inc. generate?
- Gyre Therapeutics, Inc. (GYRE) generated $9.8M in operating cash flow over the trailing twelve months.
- What is Gyre Therapeutics, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Gyre Therapeutics, Inc.'s free cash flow was $3.1M over the trailing twelve months, up 142.4% year over year.
- Where does Gyre Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
